Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,6.187614704607587e-60,59.32718985334919,8088.227427890438,"['RPL30', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL9', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPS5', 'RPL22', 'RPS3A', 'RPL37A', 'RPL24', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS2', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",1.1694591791708339e-57,0,0,55
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,5.0817392669233205e-27,21.808061179715413,1320.3503949527428,"['NDUFB8', 'UQCRB', 'NDUFB10', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'COX11', 'UQCRFS1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA1', 'ATP5F1E', 'UQCRQ', 'NDUFS6', 'NDUFS5']",4.8022436072425375e-25,0,0,32
3,Nonalcoholic fatty liver disease WP4396,5.285559883714035e-14,8.52780927185689,260.70547154087876,"['NDUFA13', 'NDUFB8', 'UQCRB', 'NDUFB10', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'COX8A', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'BAX']",3.329902726739842e-12,0,0,25
4,Oxidative phosphorylation WP623,1.8801412777462582e-11,14.027061855670103,346.4275964772299,"['ATP5PF', 'NDUFB8', 'NDUFA7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFB2', 'NDUFB1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MG', 'ATP5MF', 'ATP5ME']",8.883667537351071e-10,0,0,15
5,Mitochondrial complex I assembly model OXPHOS system WP4324,6.170002720564275e-11,14.51318670855946,341.1866856492497,"['NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFA6', 'DMAC1', 'NDUFB10', 'NDUFA5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFS6', 'NDUFS5', 'TMEM126B']",2.3322610283732958e-09,0,0,14
6,Mitochondrial complex III assembly WP4921,2.0101783031214726e-08,48.21780303030303,854.5379561623954,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",6.332061654832639e-07,0,0,7
7,Mitochondrial CIV Assembly WP4922,3.2017408487962114e-08,14.592205705102451,251.81749053713185,"['COX8A', 'COX4I1', 'COX17', 'COX11', 'COX7A2', 'COX14', 'COX5B', 'COX7C', 'SMIM20', 'PET117']",8.644700291749771e-07,0,0,10
8,Copper homeostasis WP3286,0.009561186322698263,5.461152882205514,25.394598283745434,"['CCND1', 'COX17', 'COX11', 'ATOX1']",0.22588302687374648,0,0,4
9,Cellular Proteostasis WP4918,0.01724933731802587,13.604738154613466,55.234985935534674,"['PFDN4', 'PFDN5']",0.36223608367854326,0,0,2
10,22q11.2 copy number variation syndrome WP4657,0.022531742194628935,2.9306405181720043,11.115421861959897,"['RANBP1', 'P2RX6', 'MRPL40', 'EMC10', 'CRKL', 'PAK4']",0.4258499274784868,0,0,6
11,Mitochondrial CII Assembly WP4920,0.03560680883674633,inf,inf,['SDHAF1'],0.6117897154677324,0,0,1
12,Proteasome Degradation WP183,0.04509164050612668,3.208314904909332,9.942755269652528,"['PSMB6', 'PSMD7', 'H2AFZ', 'PSMB10']",0.635899692236684,0,0,4
13,DNA Repair Pathways Full Network WP4946,0.04524409050787582,2.447009286063386,7.575165571064385,"['POLD4', 'CENPX', 'FANCL', 'RFC2', 'TDG', 'GTF2H5']",0.635899692236684,0,0,6
14,Serotonin and anxiety WP3947,0.04710368090642104,6.799875311720698,20.77636711182736,"['POMC', 'CRH']",0.635899692236684,0,0,2
15,Pyrimidine metabolism WP4022,0.054882236039988465,2.574665781738883,7.473136206569386,"['POLD4', 'POLR3GL', 'NME2', 'POLR2I', 'POLR2K']",0.6643807267009734,0,0,5
16,Complement Activation WP545,0.056243871043468646,6.043779440288168,17.394348995614713,"['C1QA', 'C1QC']",0.6643807267009734,0,0,2
17,Nucleotide Excision Repair WP4753,0.06974202777678376,3.4034375,9.063191248584998,"['POLD4', 'RFC2', 'GTF2H5']",0.7753672499889488,0,0,3
18,mRNA Processing WP411,0.07712472695677854,2.3115577889447234,5.92297695997237,"['LSM7', 'SNRPD1', 'SNRPG', 'SRSF9', 'LSM2']",0.8098096330461746,0,0,5
19,TP53 network WP1742,0.08680778911524384,4.531587697423109,11.075467356267099,"['SUMO1', 'BAX']",0.8203336071390542,0,0,2
20,DNA Mismatch Repair WP531,0.08680778911524384,4.531587697423109,11.075467356267099,"['POLD4', 'RFC2']",0.8203336071390542,0,0,2
21,MED and Pseudoachondroplasia genes WP4789,0.10307103246178013,13.573383084577115,30.84329914442127,['COL9A3'],0.8983916496455122,0,0,1
22,Selenium Micronutrient Network WP15,0.10731283750847298,2.3181357649442758,5.174095243248582,"['SELENOM', 'SELENOW', 'TXN', 'SELENOH']",0.8983916496455122,0,0,4
23,miRNA regulation of p53 pathway in prostate cancer WP3982,0.10932808434839567,3.883505521909512,8.59575877047572,"['TNFRSF10B', 'BAX']",0.8983916496455122,0,0,2
24,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.13317021038559837,3.3974438902743143,6.849679009260211,"['H2AFZ', 'RNF2']",0.9463415218801117,0,0,2
25,Peroxiredoxin 2 induced ovarian failure WP4873,0.1350163995497151,9.048092868988391,18.117530458466597,['BAX'],0.9463415218801117,0,0,1
26,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.1350163995497151,9.048092868988391,18.117530458466597,['ELOC'],0.9463415218801117,0,0,1
27,Dual hijack model of Vif in HIV infection WP3300,0.16582671396352924,6.78544776119403,12.192173471732751,['ELOC'],0.9463415218801117,0,0,1
28,MET in type 1 papillary renal cell carcinoma WP4205,0.16952649540114348,2.205,3.913315038765071,"['RPL11', 'CRKL', 'PAK4']",0.9463415218801117,0,0,3
29,Base Excision Repair WP4752,0.1836784256516403,2.7169576059850375,4.604071418951965,"['POLD4', 'TDG']",0.9463415218801117,0,0,2
30,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.19554220671124856,5.4278606965174125,8.858154843985687,['COX8A'],0.9463415218801117,0,0,1
31,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.19554220671124856,5.4278606965174125,8.858154843985687,['VEGFB'],0.9463415218801117,0,0,1
32,Cytosine methylation WP3585,0.19554220671124856,5.4278606965174125,8.858154843985687,['TDG'],0.9463415218801117,0,0,1
33,Eukaryotic Transcription Initiation WP405,0.20985660324299807,2.4695080480616642,3.8557190335970617,"['POLR2I', 'POLR2K']",0.9463415218801117,0,0,2
34,Serotonin and anxiety-related events WP3944,0.2242016871357016,4.522802653399668,6.762536332693015,['CRH'],0.9463415218801117,0,0,1
35,DNA damage response WP707,0.23400066124573973,1.8530113636363637,2.6913717738300194,"['CCND1', 'TNFRSF10B', 'BAX']",0.9463415218801117,0,0,3
36,Oxidative Damage WP3941,0.23637435421836653,2.2633000831255194,3.264444810797892,"['C1QA', 'C1QC']",0.9463415218801117,0,0,2
37,miRNA regulation of DNA damage response WP1530,0.24356210449836332,1.8116666666666668,2.5587677808645384,"['CCND1', 'TNFRSF10B', 'BAX']",0.9463415218801117,0,0,3
38,Microglia Pathogen Phagocytosis Pathway WP3937,0.2497049417944654,2.172568578553616,3.014385220670689,"['C1QA', 'C1QC']",0.9463415218801117,0,0,2
39,IL-9 signaling pathway WP22,0.25184259254910607,3.8763326226012795,5.345272821379044,['CDK9'],0.9463415218801117,0,0,1
40,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.25184259254910607,3.8763326226012795,5.345272821379044,['BAX'],0.9463415218801117,0,0,1
41,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.25184259254910607,3.8763326226012795,5.345272821379044,['CCND1'],0.9463415218801117,0,0,1
42,DNA Replication WP466,0.2630565995055586,2.0888164204872433,2.7893763354840115,"['POLD4', 'RFC2']",0.9463415218801117,0,0,2
43,Bladder cancer WP2828,0.27641097313100765,2.011268125981343,2.5862222809627236,"['CCND1', 'DAPK1']",0.9463415218801117,0,0,2
44,Wnt Signaling Pathway WP363,0.27641097313100765,2.011268125981343,2.5862222809627236,"['CCND1', 'RYK']",0.9463415218801117,0,0,2
45,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.27850103649377594,3.3914800995024876,4.3354426187249615,['CCND1'],0.9463415218801117,0,0,1
46,Homologous recombination WP186,0.27850103649377594,3.3914800995024876,4.3354426187249615,['POLD4'],0.9463415218801117,0,0,1
47,Cytosolic DNA-sensing pathway WP4655,0.3030607545945855,1.8722160116949007,2.2350926323582714,"['POLR3GL', 'POLR2K']",0.9463415218801117,0,0,2
48,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.3030607545945855,1.8722160116949007,2.2350926323582714,"['CCND1', 'BAX']",0.9463415218801117,0,0,2
49,Genes targeted by miRNAs in adipocytes WP1992,0.30421185532521855,3.014372581536761,3.5871965998674638,['TMSB4X'],0.9463415218801117,0,0,1
50,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.30421185532521855,3.014372581536761,3.5871965998674638,['ANAPC11'],0.9463415218801117,0,0,1
51,Complement system WP2806,0.31177176159600456,1.566778846153846,1.826055507863149,"['FCGR3A', 'RPS19', 'TXN']",0.9463415218801117,0,0,3
52,Airway smooth muscle cell contraction WP4962,0.3290086531701186,2.712686567164179,3.015615604948533,['PPP1R14A'],0.9463415218801117,0,0,1
53,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.3290086531701186,2.712686567164179,3.015615604948533,['CCND1'],0.9463415218801117,0,0,1
54,Androgen receptor signaling pathway WP138,0.3412801078419936,1.480909090909091,1.5920538479691073,"['CCND1', 'SUMO1', 'BAG1']",0.9463415218801117,0,0,3
55,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.3529238454342396,2.465852555404794,2.568192786265011,['CCND1'],0.9463415218801117,0,0,1
56,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.3529238454342396,2.465852555404794,2.568192786265011,['CCND1'],0.9463415218801117,0,0,1
57,Galanin receptor pathway WP4970,0.3529238454342396,2.465852555404794,2.568192786265011,['POMC'],0.9463415218801117,0,0,1
58,PPAR-alpha pathway WP2878,0.3529238454342396,2.465852555404794,2.568192786265011,['CCND1'],0.9463415218801117,0,0,1
59,Allograft Rejection WP2328,0.3686771860714587,1.5961566671556404,1.5926991561058572,"['C1QA', 'C1QC']",0.9463415218801117,0,0,2
60,Complement and Coagulation Cascades WP558,0.3686771860714587,1.5961566671556404,1.5926991561058572,"['C1QA', 'C1QC']",0.9463415218801117,0,0,2
61,Eicosanoid Synthesis WP167,0.3759887007239145,2.2601575456053067,2.2108774938309836,['TBXAS1'],0.9463415218801117,0,0,1
62,Nucleotide metabolism WP404,0.3759887007239145,2.2601575456053067,2.2108774938309836,['NME2'],0.9463415218801117,0,0,1
63,Overview of nanoparticle effects WP3287,0.3759887007239145,2.2601575456053067,2.2108774938309836,['BAX'],0.9463415218801117,0,0,1
64,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.3759887007239145,2.2601575456053067,2.2108774938309836,['CCND1'],0.9463415218801117,0,0,1
65,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.3759887007239145,2.2601575456053067,2.2108774938309836,['BAX'],0.9463415218801117,0,0,1
66,ErbB signaling pathway WP673,0.3804510038186428,1.38,1.3336290714462788,"['CCND1', 'CRKL', 'PAK4']",0.9463415218801117,0,0,3
67,Genotoxicity pathway WP4286,0.39427447050094655,1.5072042116929898,1.4027669972271057,"['RPS27', 'TRIAP1']",0.9463415218801117,0,0,2
68,Methionine De Novo and Salvage Pathway WP3580,0.398233381308602,2.0861079219288174,1.9207151534653906,['TXN'],0.9463415218801117,0,0,1
69,miRNAs involved in DNA damage response WP1545,0.398233381308602,2.0861079219288174,1.9207151534653906,['CCND1'],0.9463415218801117,0,0,1
70,Nanomaterial induced apoptosis WP2507,0.398233381308602,2.0861079219288174,1.9207151534653906,['BAX'],0.9463415218801117,0,0,1
71,Fatty Acid Biosynthesis WP357,0.398233381308602,2.0861079219288174,1.9207151534653906,['ECHDC3'],0.9463415218801117,0,0,1
72,Purinergic signaling WP4900,0.398233381308602,2.0861079219288174,1.9207151534653906,['P2RX6'],0.9463415218801117,0,0,1
73,IL-7 signaling pathway WP205,0.41968698214550865,1.9369225302061124,1.681725483543452,['CCND1'],0.9463415218801117,0,0,1
74,Statin inhibition of cholesterol production WP430,0.41968698214550865,1.9369225302061124,1.681725483543452,['APOC1'],0.9463415218801117,0,0,1
75,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.41968698214550865,1.9369225302061124,1.681725483543452,['BAX'],0.9463415218801117,0,0,1
76,7q11.23 copy number variation syndrome WP4932,0.4286406339821773,1.2716015625,1.077219962428656,"['RFC2', 'ATP5F1E', 'ATP5MC1']",0.9463415218801117,0,0,3
77,Pancreatic adenocarcinoma pathway WP4263,0.4286406339821773,1.2716015625,1.077219962428656,"['CCND1', 'BAX', 'PAK4']",0.9463415218801117,0,0,3
78,Prader-Willi and Angelman Syndrome WP3998,0.43174698854316707,1.390881769934139,1.1682232086713504,"['POMC', 'CCND1']",0.9463415218801117,0,0,2
79,Gastric Cancer Network 2 WP2363,0.440377568591679,1.8076285240464345,1.4824773838549077,['COL9A3'],0.9463415218801117,0,0,1
80,Translation Factors WP107,0.44396338371790567,1.3559850374064837,1.1010777345346132,"['EEF1B2', 'EIF1AY']",0.9463415218801117,0,0,2
81,Intraflagellar transport proteins binding to dynein WP4532,0.4603322126658762,1.6944962686567164,1.3146018103432024,['IFT22'],0.9463415218801117,0,0,1
82,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.4603322126658762,1.6944962686567164,1.3146018103432024,['TBXAS1'],0.9463415218801117,0,0,1
83,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.47957702818047515,1.594673690371671,1.1718471651061146,['CCND1'],0.9463415218801117,0,0,1
84,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.4913105852387891,1.232260258444797,0.8757412351945801,"['CCND1', 'RYK']",0.9463415218801117,0,0,2
85,Unfolded protein response WP4925,0.49813720472924644,1.505942509673853,1.0494608071264722,['TNFRSF10B'],0.9463415218801117,0,0,1
86,Fluoropyrimidine Activity WP1601,0.49813720472924644,1.505942509673853,1.0494608071264722,['TDG'],0.9463415218801117,0,0,1
87,Acute viral myocarditis WP4298,0.5140154606848425,1.178466876287542,0.7842719862976534,"['CCND1', 'BAX']",0.9463415218801117,0,0,2
88,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.5160370399319182,1.4265514532600156,0.9437732502794066,['CCND1'],0.9463415218801117,0,0,1
89,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5160370399319182,1.4265514532600156,0.9437732502794066,['BAX'],0.9463415218801117,0,0,1
90,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.5251146169494524,1.1532869952777631,0.742876811490542,"['CCND1', 'BAX']",0.9463415218801117,0,0,2
91,Ciliary landscape WP4352,0.5285236562953206,1.042230382682644,0.6645966650357442,"['IFT22', 'PSMD7', 'NDUFA5', 'SSNA1', 'MYL6B']",0.9463415218801117,0,0,5
92,The influence of laminopathies on Wnt signaling WP4844,0.5332999713153507,1.3550995024875623,0.8519120508951733,['CCND1'],0.9463415218801117,0,0,1
93,Heart Development WP1591,0.5332999713153507,1.3550995024875623,0.8519120508951733,['VEGFB'],0.9463415218801117,0,0,1
94,Leptin signaling pathway WP2034,0.5360418209630834,1.1291562759767249,0.7040776010600408,"['CCND1', 'BAX']",0.9463415218801117,0,0,2
95,Endometrial cancer WP4155,0.5360418209630834,1.1291562759767249,0.7040776010600408,"['CCND1', 'BAX']",0.9463415218801117,0,0,2
96,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.5467952208291517,1.1060104839940963,0.6676774203406042,"['CCND1', 'RYK']",0.9463415218801117,0,0,2
97,CAMKK2  Pathway WP4874,0.5499486065174846,1.2904524994077233,0.7716008408576125,['FIS1'],0.9463415218801117,0,0,1
98,Type 2 papillary renal cell carcinoma WP4241,0.5499486065174846,1.2904524994077233,0.7716008408576125,['ELOC'],0.9463415218801117,0,0,1
99,Non-small cell lung cancer WP4255,0.557373313478931,1.083790523690773,0.6334972822832333,"['CCND1', 'BAX']",0.9463415218801117,0,0,2
100,Hippo-Merlin Signaling Dysregulation WP4541,0.5631877930805905,1.02873417721519,0.5906396508352159,"['PPP1R14A', 'CCND1', 'PAK4']",0.9463415218801117,0,0,3
101,Aryl Hydrocarbon Receptor Pathway WP2873,0.5660047525519639,1.2316824966078697,0.7010155466797471,['BAX'],0.9463415218801117,0,0,1
102,Endothelin Pathways WP2197,0.5660047525519639,1.2316824966078697,0.7010155466797471,['RIIAD1'],0.9463415218801117,0,0,1
103,Melanoma WP4685,0.5677749220053605,1.0624419343797369,0.6013742236539321,"['CCND1', 'BAX']",0.9463415218801117,0,0,2
104,Apoptosis WP254,0.5779991749536811,1.0419144446575868,0.5711596169406835,"['TNFRSF10B', 'BAX']",0.9463415218801117,0,0,2
105,Retinoblastoma gene in cancer WP2446,0.5779991749536811,1.0419144446575868,0.5711596169406835,"['CCND1', 'H2AFZ']",0.9463415218801117,0,0,2
106,Signaling of Hepatocyte Growth Factor Receptor WP313,0.581489444261234,1.1780229288340904,0.638679808787345,['CRKL'],0.9463415218801117,0,0,1
107,Vitamin D-sensitive calcium signaling in depression WP4698,0.581489444261234,1.1780229288340904,0.638679808787345,['KCNQ2'],0.9463415218801117,0,0,1
108,Neural Crest Cell Migration during Development WP4564,0.581489444261234,1.1780229288340904,0.638679808787345,['PAK4'],0.9463415218801117,0,0,1
109,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.581489444261234,1.1780229288340904,0.638679808787345,['NDUFA13'],0.9463415218801117,0,0,1
110,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.5964229713706539,1.128834991708126,0.5833877712101018,['CDK9'],0.9463415218801117,0,0,1
111,Amyotrophic lateral sclerosis (ALS) WP2447,0.5964229713706539,1.128834991708126,0.5833877712101018,['BAX'],0.9463415218801117,0,0,1
112,miRNA regulation of prostate cancer signaling pathways WP3981,0.5964229713706539,1.128834991708126,0.5833877712101018,['CCND1'],0.9463415218801117,0,0,1
113,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.5964229713706539,1.128834991708126,0.5833877712101018,['BAX'],0.9463415218801117,0,0,1
114,Hedgehog Signaling Pathway WP4249,0.5964229713706539,1.128834991708126,0.5833877712101018,['CCND1'],0.9463415218801117,0,0,1
115,Corticotropin-releasing hormone signaling pathway WP2355,0.5979135330879394,1.0031402974046366,0.5159242126075133,"['POMC', 'CRH']",0.9463415218801117,0,0,2
116,Neural Crest Cell Migration in Cancer WP4565,0.6108249051516323,1.0835820895522388,0.534146299262673,['PAK4'],0.9463415218801117,0,0,1
117,IL-2 signaling pathway WP49,0.6247141234216421,1.0418101798698813,0.49013120114670883,['CRKL'],0.9463415218801117,0,0,1
118,Sleep regulation WP3591,0.6381088351993098,1.0031324857195505,0.4506536801009325,['CRH'],0.9463415218801117,0,0,1
119,TGF-beta Signaling Pathway WP366,0.648690563537806,0.9020833333333333,0.3904211845902048,"['PARD6A', 'CCND1', 'SUMO1']",0.9463415218801117,0,0,3
120,Regulation of Actin Cytoskeleton WP51,0.648690563537806,0.9020833333333333,0.3904211845902048,"['TMSB4X', 'BRK1', 'PAK4']",0.9463415218801117,0,0,3
121,Splicing factor NOVA regulated synaptic proteins WP4148,0.6510266045393852,0.9672174840085288,0.41513435817068345,['KCNQ2'],0.9463415218801117,0,0,1
122,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.6510266045393852,0.9672174840085288,0.41513435817068345,['PAK4'],0.9463415218801117,0,0,1
123,Development of ureteric collection system WP5053,0.6510266045393852,0.9672174840085288,0.41513435817068345,['CCND1'],0.9463415218801117,0,0,1
124,Regulation of Microtubule Cytoskeleton WP2038,0.6510266045393852,0.9672174840085288,0.41513435817068345,['PARD6A'],0.9463415218801117,0,0,1
125,Hepatitis C and Hepatocellular Carcinoma WP3646,0.6510266045393852,0.9672174840085288,0.41513435817068345,['CCND1'],0.9463415218801117,0,0,1
126,Apoptosis Modulation and Signaling WP1772,0.6533894689848498,0.9023275145469659,0.3840142555377174,"['TNFRSF10B', 'BAX']",0.9463415218801117,0,0,2
127,TNF-alpha signaling pathway WP231,0.6533894689848498,0.9023275145469659,0.3840142555377174,"['BAX', 'TXN']",0.9463415218801117,0,0,2
128,Integrated breast cancer pathway WP1984,0.6628928256298684,0.8823097826086956,0.36275456672879197,"['CCND1', 'BAX', 'FAU']",0.9463415218801117,0,0,3
129,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.670476207233173,0.8730592872657067,0.34902034622278366,"['CCND1', 'BAX']",0.9463415218801117,0,0,2
130,Integrated Cancer Pathway WP1971,0.6754984817505943,0.9025704809286899,0.35408234315932713,['BAX'],0.9463415218801117,0,0,1
131,VEGFA-VEGFR2 Signaling Pathway WP3888,0.6788074681251379,0.8904445807999107,0.34497403041047175,"['RPL18A', 'CCND1', 'TMSB4X', 'RPLP2', 'RPL26', 'ELOC', 'TXN', 'RPL10A', 'TMSB10']",0.9463415218801117,0,0,9
132,Wnt signaling WP428,0.6868755553707198,0.8456203241895262,0.3176168078559082,"['CCND1', 'RYK']",0.9463415218801117,0,0,2
133,Netrin-UNC5B signaling pathway WP4747,0.6870846931409128,0.8733750601829562,0.3277756641425572,['DAPK1'],0.9463415218801117,0,0,1
134,Prostaglandin Synthesis and Regulation WP98,0.6870846931409128,0.8733750601829562,0.3277756641425572,['TBXAS1'],0.9463415218801117,0,0,1
135,IL-3 signaling pathway WP286,0.7090336987463081,0.820292477008895,0.28205939223247384,['CRKL'],0.9463415218801117,0,0,1
136,DNA damage response (only ATM dependent) WP710,0.7176629595605629,0.7955845679917852,0.26393934595116086,"['CCND1', 'BAX']",0.9463415218801117,0,0,2
137,TYROBP causal network in microglia WP3945,0.7194253023533193,0.7960930640913082,0.2621554974353305,['C1QC'],0.9463415218801117,0,0,1
138,Modulators of TCR signaling and T cell activation WP5072,0.7194253023533193,0.7960930640913082,0.2621554974353305,['NDUFB10'],0.9463415218801117,0,0,1
139,Exercise-induced Circadian Regulation WP410,0.7194253023533193,0.7960930640913082,0.2621554974353305,['SUMO1'],0.9463415218801117,0,0,1
140,Small cell lung cancer WP4658,0.7249513409245021,0.7839820738010047,0.25216841602408385,"['CCND1', 'BAX']",0.9463415218801117,0,0,2
141,Interferon type I signaling pathways WP585,0.7294466647702452,0.7732764747690121,0.24394477611331142,['CRKL'],0.9463415218801117,0,0,1
142,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7294466647702452,0.7732764747690121,0.24394477611331142,['BAX'],0.9463415218801117,0,0,1
143,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.7294466647702452,0.7732764747690121,0.24394477611331142,['PPP1R14A'],0.9463415218801117,0,0,1
144,Glucocorticoid Receptor Pathway WP2880,0.7391109456264612,0.7517274737423991,0.22725265774587886,['SRGN'],0.9463415218801117,0,0,1
145,Focal Adhesion WP306,0.7396644811634812,0.7945599292348519,0.23960637942775365,"['CCND1', 'VEGFB', 'CRKL', 'PAK4']",0.9463415218801117,0,0,4
146,Kit receptor signaling pathway WP304,0.748430837852865,0.7313432835820896,0.21192608267318525,['CRKL'],0.9463415218801117,0,0,1
147,Spinal Cord Injury WP2431,0.7525314284084081,0.7407508625696034,0.21060474287706826,"['BCAN', 'CCND1']",0.9463415218801117,0,0,2
148,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.7574185844129266,0.7120319455354804,0.1978304051317067,['TNFRSF10B'],0.9463415218801117,0,0,1
149,Cardiac Hypertrophic Response WP2795,0.7574185844129266,0.7120319455354804,0.1978304051317067,['CDK9'],0.9463415218801117,0,0,1
150,Notch Signaling Pathway Netpath WP61,0.7574185844129266,0.7120319455354804,0.1978304051317067,['CCND1'],0.9463415218801117,0,0,1
151,p53 transcriptional gene network WP4963,0.7574185844129266,0.7120319455354804,0.1978304051317067,['BAX'],0.9463415218801117,0,0,1
152,EGF/EGFR signaling pathway WP437,0.761558627903221,0.7504861111111111,0.20442350058139505,"['NDUFA13', 'NEDD8', 'CRKL']",0.9463415218801117,0,0,3
153,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7660859939029475,0.6937109325169026,0.18484680609363988,['IFI27L2'],0.9463415218801117,0,0,1
154,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.7825049575394698,0.6597500303361242,0.16180700759378933,['PSMD7'],0.9513538835410417,0,0,1
155,Phosphodiesterases in neuronal function WP4222,0.7825049575394698,0.6597500303361242,0.16180700759378933,['PDE1C'],0.9513538835410417,0,0,1
156,Cell cycle WP179,0.7894238829630782,0.6841125035512484,0.16175967503182873,"['CCND1', 'ANAPC11']",0.9513538835410417,0,0,2
157,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.790278093735151,0.6439824686093343,0.15157439711243167,['TMSB4X'],0.9513538835410417,0,0,1
158,Circadian rhythm related genes WP3594,0.8013892289409865,0.6982112068965517,0.1545899107858354,"['CAVIN3', 'CRH', 'RPS27A']",0.953186534152986,0,0,3
159,IL-18 signaling pathway WP4754,0.8114549669437033,0.709866772193642,0.14830990008445274,"['NRN1', 'TMSB4X', 'COX17', 'BAX']",0.953186534152986,0,0,4
160,Endochondral Ossification with Skeletal Dysplasias WP4808,0.8119737142784695,0.6008844665561084,0.12515660971417453,['CTSV'],0.953186534152986,0,0,1
161,Endochondral Ossification WP474,0.8119737142784695,0.6008844665561084,0.12515660971417453,['CTSV'],0.953186534152986,0,0,1
162,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8186960304558509,0.5877676833225178,0.117578464600674,['BAX'],0.9551453688651594,0,0,1
163,G1 to S cell cycle control WP45,0.8251785828237607,0.5752090610775907,0.1105295571509465,['CCND1'],0.9568021604520905,0,0,1
164,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8488772975916127,0.5298995219978538,0.08681907094884432,['CDK9'],0.9665624069393853,0,0,1
165,Head and Neck Squamous Cell Carcinoma WP4674,0.8488772975916127,0.5298995219978538,0.08681907094884432,['CCND1'],0.9665624069393853,0,0,1
166,Mesodermal commitment pathway WP2857,0.8489384103277141,0.5932421693020197,0.0971544627149164,"['CCND1', 'RPL38']",0.9665624069393853,0,0,2
167,Alzheimer's disease WP2059,0.8693702676557915,0.49118046132971505,0.06875846650408257,['ATP5MD'],0.9690669348115496,0,0,1
168,T-cell receptor (TCR) signaling pathway WP69,0.8693702676557915,0.49118046132971505,0.06875846650408257,['CRKL'],0.9690669348115496,0,0,1
169,Glioblastoma signaling pathways WP2261,0.8740446657522544,0.482364960909737,0.06493780385700479,['CCND1'],0.9690669348115496,0,0,1
170,Myometrial relaxation and contraction pathways WP289,0.8796628441721026,0.5449003753243155,0.0698652606828056,"['CRH', 'IGFBP6']",0.9690669348115496,0,0,2
171,Breast cancer pathway WP4262,0.8830701292205709,0.5394014962593516,0.06707493206001038,"['CCND1', 'BAX']",0.9690669348115496,0,0,2
172,B Cell Receptor Signaling Pathway WP23,0.8870902043023006,0.4577114427860697,0.054837769864342696,['CRKL'],0.9690669348115496,0,0,1
173,Wnt signaling pathway and pluripotency WP399,0.8870902043023006,0.4577114427860697,0.054837769864342696,['CCND1'],0.9690669348115496,0,0,1
174,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8950293492320183,0.4426229508196721,0.04908634029159315,['POMC'],0.9690669348115496,0,0,1
175,Nuclear Receptors Meta-Pathway WP2882,0.8978223174796263,0.5978835978835979,0.06444174461753077,"['SRGN', 'CCND1', 'BAX', 'TXN']",0.9690669348115496,0,0,4
176,G Protein Signaling Pathways WP35,0.902411537179009,0.4284924583432046,0.04399958239790804,['PDE1C'],0.9690669348115496,0,0,1
177,Male infertility WP4673,0.9186794869575359,0.3968027509511267,0.03365600790926752,['CDK9'],0.9809628420055044,0,0,1
178,Integrin-mediated Cell Adhesion WP185,0.9271106506705458,0.37993132926914724,0.028754098222915126,['PAK4'],0.9844040054872649,0,0,1
179,Gastrin signaling pathway WP4659,0.9346696040922347,0.3644278606965174,0.02462153953651789,['CCND1'],0.9868857830918009,0,0,1
180,NRF2 pathway WP2884,0.9593628076865499,0.30960141819637443,0.012844111087655931,['TXN'],0.9906325450691197,0,0,1
181,Chemokine signaling pathway WP3929,0.9608210357465421,0.3060549525101764,0.012232133319567925,['CRKL'],0.9906325450691197,0,0,1
182,Hepatitis B infection WP4666,0.9635827407555334,0.2991984521835268,0.01109934092941533,['BAX'],0.9906325450691197,0,0,1
183,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9673654051418714,0.28946664526828225,0.009604208001655132,['CDCA7L'],0.9906325450691197,0,0,1
184,Vitamin D Receptor Pathway WP2877,0.9685370754071839,0.28636074944426804,0.009154528086036652,['CCND1'],0.9906325450691197,0,0,1
185,Metapathway biotransformation Phase I and II WP702,0.9696667769195086,0.28332024090075936,0.00872705542823305,['KCNAB3'],0.9906325450691197,0,0,1
186,PI3K-Akt signaling pathway WP4172,0.9841074325443774,0.3786438679245283,0.0060659537017436985,"['CCND1', 'VEGFB', 'COL9A3']",0.9976715454955517,0,0,3
187,Ras signaling WP4223,0.9887117702877497,0.2200676943153087,0.002498302068972982,['PAK4'],0.9976715454955517,0,0,1
188,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9945181698809261,0.268574794170353,0.0014763316026353867,"['CAB39L', 'VEGFB']",0.9976715454955517,0,0,2
189,MAPK Signaling Pathway WP382,0.9976715454955517,0.16206844565053521,0.00037780902876765373,['CRKL'],0.9976715454955517,0,0,1
